This study provides compelling evidence for the dysregulation of TGF-β superfamily members in depression and highlights the potential of GDF15, TGF-β1, and GDF11 as promising biomarkers for both diagnosis and severity assessment. This evidence concerns the gene GDF15 and depressive symptom measurement.